Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ChemoCentryx, Inc. | 10%+ Owner | Common Stock, par value $0.001 per share | 5.19M | $265M | $50.95 | Oct 12, 2021 | Indirect |
Cara Therapeutics, Inc. | 10%+ Owner | Common Stock, par value $0.001 per share | 7.4M | $9.02M | $1.22 | Oct 20, 2021 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CARA | Cara Therapeutics, Inc. | Oct 20, 2021 | 0 | $0 | 3 | Oct 21, 2021 | 10%+ Owner |
CCXI | ChemoCentryx, Inc. | Oct 12, 2021 | 1 | -$158M | 4 | Oct 13, 2021 | 10%+ Owner |